EFTUD2 and neurodevelopmental disorder: By mechanistically linking EFTUD2 mutations to a unified pathway of splicing‐dependent apoptosis, this work repositions MFDM within the emerging class of spliceosomopathies and establishes a framework for targeted therapeutic development in neurodevelopmental disorders.